In this fund overview we look at the HAN-GINS Index Healthcare Innovation UCITS ETF.

It goes beyond big pharma to capture the companies at the forefront of medical innovation and technology.

These technologies include: Robotics, Nanotechnology, Genome Sequencing, Healthcare Trackers, Biological Engineering, Bioinformatics, Neuroscience and Medical Devices. 

The fund has a total expense ratio of 75 basis points and holds equities from Emerging Markets as well as Developed Markets giving it global coverage.

It is available in US Dollars, British pounds and Euros and is domiciled in Ireland.

The fund tracks the Index Advanced Life Sciences & Smart Healthcare Thematic Index.

The index goes beyond traditional healthcare definitions and delivers a specialist index to track an emerging theme.

The fund targets buy and hold investors who seek to profit from companies that are addressing the challenges faced by an ageing population – including wealth managers, private banks, asset managers, IFAs and hedge funds